Ken Griffin, Citadel: This Tuesday morning in the hedge fund universe began amid some bullish moves made by Ken Griffin and his hedge fund Citadel Investment Group. In two filings with the SEC, Citadel disclosed that it currently owns almost 1.5 million shares, or 5.2% of BJ’s Restaurants, Inc. (NASDAQ:BJRI) and 1.4 million shares of Repros Therapeutics Inc (NASDAQ:RPRX), equivalent to 6.0% of the company. The value of each stake amounts to $44.9 million and $40.4 million respectively, at current market prices.
Repros Therapeutics recently announced that it conducted the second second pivotal efficacy study for Androxal, a drug that is developed for helping men with low testosterone levels caused by secondary hypogonadism. The study showed no site anomalies, the company said in a statement.
The second purchase of Citadel involved around 1.4 million shares of BJ’s Restaurants. Citadel boosted its stake in the company, after previously dumping 387,300 shares, as disclosed in the hedge fund’s most recent 13F. BJ’s Restaurants currently operates around 140 restaurants and for the second quarter of fiscal 2013, the company showed a 10% increase in revenues, which totaled around $199 million, and a net income of $8.6 million, or $0.30 per share. BJ’s Restaurants plans to open 17 new locations during its fiscal 2013, with seven in the current quarter. Check back here for more updates on Ken Griffin and Citadel.